Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT

Yishan Ye; Myriam Labopin; Jia Chen; Depei Wu; Tobias Gedde-Dahl; Didier Blaise; Gérard Socie; Edouard Forcade; Urpu Salmenniemi; Sébastien Maury; Jurjen Versluis; Ali Bazarbachi; Arnon Nagler; Eolia Brissot; Lin Li; Yi Luo; Jimin Shi; Fabio Ciceri; He Huang; Mohamad Mohty; Norbert Claude Gorin

doi:10.1038/s41408-024-01072-0

Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT

Yishan Ye, Myriam Labopin, Jia Chen, Depei Wu, Tobias Gedde-Dahl, Didier Blaise, Gérard Socie, Edouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang^*, Mohamad Mohty^*Norbert Claude Gorin^*

^*Corresponding author for this work

Hematology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Downloads (Pure)

Original language	English
Article number	85
Journal	Blood Cancer Journal
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41408-024-01072-0
Publication status	Published - 27 May 2024

Access to Document

10.1038/s41408-024-01072-0Licence: CC BY

s41408-024-01072-0Final published version, 643 KBLicence: CC BY

Cite this

Ye, Y., Labopin, M., Chen, J., Wu, D., Gedde-Dahl, T., Blaise, D., Socie, G., Forcade, E., Salmenniemi, U., Maury, S., Versluis, J., Bazarbachi, A., Nagler, A., Brissot, E., Li, L., Luo, Y., Shi, J., Ciceri, F., Huang, H., ... Gorin, N. C. (2024). Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT. Blood Cancer Journal, 14(1), Article 85. https://doi.org/10.1038/s41408-024-01072-0

@article{d209ace1d07b4f5d91a332b3a90268b9,

title = "Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT",

author = "Yishan Ye and Myriam Labopin and Jia Chen and Depei Wu and Tobias Gedde-Dahl and Didier Blaise and G{\'e}rard Socie and Edouard Forcade and Urpu Salmenniemi and S{\'e}bastien Maury and Jurjen Versluis and Ali Bazarbachi and Arnon Nagler and Eolia Brissot and Lin Li and Yi Luo and Jimin Shi and Fabio Ciceri and He Huang and Mohamad Mohty and Gorin, {Norbert Claude}",

year = "2024",

month = may,

day = "27",

doi = "10.1038/s41408-024-01072-0",

language = "English",

volume = "14",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "1",

}

Ye, Y, Labopin, M, Chen, J, Wu, D, Gedde-Dahl, T, Blaise, D, Socie, G, Forcade, E, Salmenniemi, U, Maury, S, Versluis, J, Bazarbachi, A, Nagler, A, Brissot, E, Li, L, Luo, Y, Shi, J, Ciceri, F, Huang, H, Mohty, M & Gorin, NC 2024, 'Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT', Blood Cancer Journal, vol. 14, no. 1, 85. https://doi.org/10.1038/s41408-024-01072-0

TY - JOUR

T1 - Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement

T2 - a study from the Global Committee and the ALWP of the EBMT

AU - Ye, Yishan

AU - Labopin, Myriam

AU - Chen, Jia

AU - Wu, Depei

AU - Gedde-Dahl, Tobias

AU - Blaise, Didier

AU - Socie, Gérard

AU - Forcade, Edouard

AU - Salmenniemi, Urpu

AU - Maury, Sébastien

AU - Versluis, Jurjen

AU - Bazarbachi, Ali

AU - Nagler, Arnon

AU - Brissot, Eolia

AU - Li, Lin

AU - Luo, Yi

AU - Shi, Jimin

AU - Ciceri, Fabio

AU - Huang, He

AU - Mohty, Mohamad

AU - Gorin, Norbert Claude

PY - 2024/5/27

Y1 - 2024/5/27

UR - http://www.scopus.com/inward/record.url?scp=85194520460&partnerID=8YFLogxK

U2 - 10.1038/s41408-024-01072-0

DO - 10.1038/s41408-024-01072-0

M3 - Comment/Letter to the editor

C2 - 38802349

AN - SCOPUS:85194520460

SN - 2044-5385

VL - 14

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 1

M1 - 85

ER -

Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT

Access to Document

Other files and links

Cite this